You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
Working hand in hand to provide innovative diagnostics solutions to those who need it most
playicon
Take Aim Stop Disease
playicon
videoCtrl
/
fullScreen
Update Required
To play the media you will need to either update your browser to a recent version or update your
Flash plugin.
Universal access to quality healthcare and medical innovation remains a global challenge.
To address this challenge, many of the world's top relief and aid organizations have joined together with an ambitious goal: to end stop many diseases.
In 2014, Roche announced, the Global Access Program. In 2019, the Program was expanded to include Tuberculosis (TB), Hepatitis B and C (HBV and HCV), and Human Papillomavirus (HPV).
Roche continues to partner with national governments, local healthcare facilities, communities and international agencies, including UNAIDS, CHAI, Unitaid, the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), Global Fund, and Centres for Disease Control (CDC), to establish The Global Access Program that would go beyond providing diagnostic tests.
Since its inception, the program has expanded substantially in menu and geographic footprint to provide increased access to diagnostics at affordable pricing for qualifying organizations in eligible countries with the highest disease burden.
